Canopy Growth Is Restating Two Years of Financials Before June 15 Earnings -- Here's What CGC Investors Need to Know Right Now

Canopy Growth announced it will restate financial results for two years due to a technical accounting error involving share-settled warrants that should have been classified as liabilities rather than equity. The company states the restatement won't impact revenue, operating income, cash flows, or key performance metrics. However, the stock remains a risky penny stock in a struggling marijuana sector facing intense competition and illicit market pressures. Most investors should avoid the stock until it achieves sustainable profitability and the restatement is complete.

05/22/2026, 11:15 PM • The Motley Fool

Is Aurora Cannabis Stock Ready to 10X in the Next Pot Boom?

Aurora Cannabis has lost 96% of its value since 2021 and faces significant challenges despite recent U.S. cannabis reclassification from Schedule I to Schedule III. The company has no meaningful U.S. market presence after shutting down its Reliva CBD operations in 2023, and with weak revenue growth and consistent losses, it is unlikely to capitalize on potential industry growth. The stock is viewed as a wealth destroyer rather than a 10x opportunity.

02/26/2026, 6:14 AM • The Motley Fool

Recreational Cannabis Market Report 2026-2035: A $3.32 Billion Market by 2030 - AI-Enabled Product Innovation, Novel Cannabis Beverages and Experience-Based Offerings Reshape Premiumization

The recreational cannabis market is projected to grow from $2.24 billion in 2025 to $3.32 billion by 2030, with a CAGR of 7.8-8.2%. Growth is driven by increasing legalization, public acceptance, demand for high-THC products, and innovation in premium edibles, beverages, and vape formats. Key players are launching innovative products and pursuing strategic acquisitions to capitalize on expanding market opportunities.

02/20/2026, 5:59 AM • GlobeNewswire

Trump's Cannabis Rescheduling Order Could Finally Kill A Crushing Tax Rule And Transform US Weed Stocks, Says Expert

President Trump's executive order to reschedule cannabis to Schedule 3 could eliminate Section 280E of the Internal Revenue Code, allowing U.S. cannabis operators to deduct business expenses for the first time. This represents the most significant federal cannabis policy shift in over 50 years. However, challenges remain including inability to list on major exchanges and lack of banking safe harbor provisions.

01/19/2026, 8:16 AM • Benzinga

Do These 2 Cannabis Stocks Have a Future?

President Trump's executive order rescheduling cannabis from Schedule 1 to Schedule 3 has improved the regulatory landscape for the cannabis industry, offering easier banking access and business expense deductions. However, analyst Prosper Junior Bakiny argues that Canopy Growth and Aurora Cannabis lack attractive investment prospects despite this development, citing ongoing federal illegality, interstate commerce restrictions, and poor financial performance in their home market.

12/28/2025, 11:09 PM • The Motley Fool

High Hopes: Pot Stocks Blaze As Trump Eyes Rescheduling

President Trump is considering rescheduling marijuana from Schedule I to Schedule III, which could potentially remove tax burdens on cannabis businesses and improve their financial prospects.

12/17/2025, 11:26 AM • Benzinga

Canopy Growth To Acquire MTL Cannabis

Canopy Growth will acquire MTL Cannabis for approximately 125 million Canadian dollars in a cash-and-stock transaction, expanding its medical cannabis market presence in Canada and improving national distribution capabilities.

12/15/2025, 11:36 AM • Benzinga

Why Aurora Cannabis Stock Just Rocketed Higher

President Trump is considering rescheduling marijuana from Schedule I to Schedule III, which could make cannabis business operations easier and potentially boost marijuana companies like Aurora Cannabis.

12/12/2025, 12:12 PM • The Motley Fool

Rigetti Computing Stock Plunged 42% Last Month. Here's Why.

Quantum computing company Rigetti Computing experienced a significant stock decline in November 2025, with Q3 revenues falling 18% and net losses expanding to $201 million, reflecting ongoing challenges in the emerging quantum computing market.

12/03/2025, 7:30 PM • The Motley Fool

Prediction: President Trump Will Legalize Marijuana in 2026

A video posted on Truth Social by the Commonwealth Project suggests potential federal marijuana legalization, with implications for Medicare coverage of medical marijuana and significant stock market reactions in cannabis companies.

10/05/2025, 3:23 PM • The Motley Fool

1 Major Reason Cannabis Stocks Surged This Week

Marijuana stocks experienced significant gains after Donald Trump's video promoting hemp-derived CBD benefits and potential marijuana reclassification, with several cannabis companies and ETFs seeing notable price increases.

10/01/2025, 12:20 PM • The Motley Fool

How Trump Has Fired Up Cannabis Stocks

Donald Trump's video on Truth Social praising hemp-derived CBD's health benefits triggered a significant surge in cannabis and CBD-related stocks, with some companies experiencing dramatic price increases.

09/29/2025, 4:12 PM • Investing

President Trump Lights Up Cannabis Stocks With Pro-CBD Truth Social Post

President Trump posted a video on Truth Social promoting CBD's potential health benefits, suggesting Medicare coverage and potential healthcare system integration. This sparked a significant rally in cannabis stocks, with multiple companies seeing substantial price increases.

09/29/2025, 10:36 AM • Benzinga

$80 Bn Medical Marijuana Markets - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast to 2032

The global medical marijuana market is projected to grow from $30 billion in 2025 to $80 billion by 2032, driven by evolving regulations, increased healthcare acceptance, and therapeutic potential for managing conditions like chronic pain and mental health disorders.

07/31/2025, 10:59 AM • GlobeNewswire

Canada Legal Cannabis Market Report 2025 | Expansion of Cannabis 2.0 and 3.0 Products Reshaping Consumer Preferences and Driving Growth - Competition, Forecast & Opportunities to 2030

Canada's legal cannabis market is projected to grow from $3.61 billion in 2024 to $7.19 billion by 2030, driven by medical cannabis adoption, innovative product formats, and expanding consumer preferences.

07/04/2025, 4:49 AM • GlobeNewswire